| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_107e17d01f9d45c372d48f1b5e610033 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-065 |
| filingDate |
1994-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a2f00e9cf3aa98de20ad498947f2e7e |
| publicationDate |
1996-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0696204-A1 |
| titleOfInvention |
Recombinant fowlpox viruses and uses thereof |
| abstract |
The present invention provides a recombinant fowlpox virus designated S-FPV-097. The present invention also provides a vaccine which comprises an effective immunizing amount of the recombinant fowlpox virus designated S-FPV-097 and a suitable carrier. The present invention further provides a method of immunizing an animal against disease caused by fowlpox virus, Newcastle disease virus, and infectious laryngotracheitis virus which comprises administering to an animal an effective immunizing dose of the vaccine of the present invention and a suitable carrier. The present invention further provides recombinant fowlpox viruses designated S-FPV-095, S-FPV-074, S-FPV-081, and S-FPV-085. The present invention further provides a vaccine which comprises an effective immunizing amount of the fowlpox viruses of the present invention and a suitable carrier. The present invention further provides a method of immunizing an animal against disease caused by fowlpox virus, Newcastle disease virus, infectious laryngotracheitis virus or Marek's disease virus which comprises administering to an animal an effective immunizing dose of the vaccines of the present invention. |
| priorityDate |
1993-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |